Finance

Beta
Lists
FBIO:NASDAQ
Fortress Biotech Inc
2,80 USD
-0,36%
(-0,0100) 1D
2,88 USD
+2,86% (+0,080)
Pre-market
Closed: 29-май, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIO...
Open
2,80 USD
High
2,84 USD
Low
2,72 USD
Mkt. cap
93,01 млн
Avg. vol.
344,97 миң
Volume
1,23 миң
P/E ratio
0,88
52-wk high
4,53 USD
52-wk low
1,70 USD
EPS
3,18 USD
Beta
1,16
Shares outstanding
33,22 млн
No. of employees
78
Open
2,80 USD
High
2,84 USD
Low
2,72 USD
Mkt. cap
93,01 млн
Avg. vol.
344,97 миң
Volume
1,23 миң
P/E ratio
0,88
52-wk high
4,53 USD
52-wk low
1,70 USD
EPS
3,18 USD
Beta
1,16
Shares outstanding
33,22 млн
No. of employees
78
News stories
From sources across the web
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersБэй Харбор Айлендс, Флорида, Америка Кошмо Штаттары
Sector-
Websitefortressbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
16,41 млн
17,63 млн
16,08 млн
16,04 млн
Cost of goods sold
13,06 млн
5,96 млн
5,07 млн
6,22 млн
Cost of revenue
13,06 млн
5,96 млн
5,07 млн
6,22 млн
Research and development expenses
-
-
-
540,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38,76 млн
17,42 млн
14,73 млн
15,89 млн
Operating expense
39,82 млн
18,48 млн
15,80 млн
17,56 млн
Total operating expenses
52,89 млн
24,44 млн
20,87 млн
23,78 млн
Operating income
-36,47 млн
-6,81 млн
-4,79 млн
-7,74 млн
Other non operating income
-412,00 миң
32,74 млн
5,00 миң
152,83 млн
EBT including unusual items
-11,65 млн
8,85 млн
-6,21 млн
142,29 млн
EBT excluding unusual items
-38,78 млн
23,93 млн
-6,19 млн
142,29 млн
Income tax expense
-
26,00 миң
-816,00 миң
5,13 млн
Effective tax rate
-
0,29%
13,13%
3,61%
Other operating expenses
-
-
-
-
Net income
15,49 млн
5,85 млн
-3,94 млн
110,37 млн
Net profit margin
94,35%
33,18%
-24,49%
688,20%
Earnings per share
-0,51
-
-
-
Interest and investment income
622,00 миң
736,00 миң
637,00 миң
570,00 миң
Interest expense
-2,52 млн
-2,74 млн
-2,04 млн
-3,37 млн
Net interest expenses
-1,90 млн
-2,01 млн
-1,40 млн
-2,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-35,32 млн
-5,65 млн
-3,63 млн
-6,52 млн
Gain or loss from assets sale
-27,13 млн
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer